MetaCap

Protara Therapeutics Insider Trades

NASDAQ: TARAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.28-0.12 (-5.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
3 · $1.01M
Shares bought / sold
0 / 239.42K
Net activity
Net selling $1.0 million

Protara Therapeutics insider activity

Over the last 12 months, Protara Therapeutics insiders reported 23 transactions on SEC Form 4: 0 open-market purchases and 3 sales. Insiders bought $0 and sold $1.0 million worth of stock, for net insider selling of $1.0 million. The largest seller was Shefferman Jesse, with $882,160 in reported sales.

The most recent filing shows Shefferman Jesse (CEO and President) reporting a transaction in 14,000 shares on Jun 30, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TARA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

TARA insider transactions

Protara Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Jun 30, 2026Shefferman JesseCEO and PresidentGift5,000—Form 4
Jun 30, 2026Shefferman JesseCEO and PresidentGift4,000—Form 4
Jun 30, 2026Shefferman JesseCEO and PresidentGift7,000—Form 4
Jun 30, 2026Shefferman JesseCEO and PresidentGift14,000—Form 4
Jun 29, 2026Shefferman JesseCEO and PresidentSale215,687$882.16KForm 4
Jun 29, 2026Shefferman JesseCEO and PresidentOption exercise215,687$411.96KForm 4
Jun 2, 2026CONKLING WILLIAMChief Commercial OfficerTax withholding6,008$26.07KForm 4
Apr 8, 2026Zummo JacquelineChief R&D OfficerSale1,134$6.12KForm 4
Apr 1, 2026Zummo JacquelineChief R&D OfficerSale22,598$118.87KForm 4
Jan 26, 2026Zummo JacquelineChf Scientific Operations OffTax withholding3,724$24.84KForm 4
Jan 26, 2026Shefferman JesseCEO and PresidentTax withholding8,732$58.24KForm 4
Jan 26, 2026Fry HannahVP, ControllerTax withholding1,457$9.72KForm 4
Jan 26, 2026Fabbio PatrickChief Financial OfficerTax withholding3,261$21.75KForm 4
Jan 20, 2026Fabbio PatrickChief Financial OfficerTax withholding3,063$17.15KForm 4
Jan 20, 2026Fry HannahVP, ControllerTax withholding2,132$11.94KForm 4
Jan 20, 2026Zummo JacquelineChf Scientific Operations OffTax withholding6,578$36.84KForm 4
Jan 20, 2026Shefferman JesseCEO and PresidentTax withholding16,322$91.40KForm 4
Jan 16, 2026Zummo JacquelineChf Scientific Operations OffAward30,000—Form 4
Jan 16, 2026Nicacio Leonardo VianaChief Medical OfficerAward26,000—Form 4
Jan 16, 2026Fry HannahVP, ControllerAward9,500—Form 4
Jan 16, 2026Fabbio PatrickChief Financial OfficerAward28,000—Form 4
Jan 16, 2026Shefferman JesseCEO and PresidentAward87,000—Form 4
Jan 16, 2026CONKLING WILLIAMChief Commercial OfficerAward26,000—Form 4
Jun 27, 2025Shefferman JesseCEO and PresidentGift3,367—Form 4
Jun 27, 2025Shefferman JesseCEO and PresidentGift10,200—Form 4
Jun 26, 2025Shefferman JesseCEO and PresidentGift3,400—Form 4
Jun 26, 2025Shefferman JesseCEO and PresidentGift1,700—Form 4
Jun 24, 2025Shefferman JesseCEO and PresidentGift300,000—Form 4
Jun 2, 2025CONKLING WILLIAMChief Commercial OfficerAward50,000—Form 4
May 14, 2025Levy Richard SDirectorBuy20,000$63.80KForm 4
May 14, 2025Levy Richard SDirectorBuy20,000$63.80KForm 4
Apr 15, 2025Nicacio Leonardo VianaChief Medical OfficerAward50,000—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related